Covington Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$7K Buy
+100
New +$6.34K ﹤0.01% 864
2021
Q2
Sell
-267
Closed -$16K 939
2021
Q1
$16K Sell
267
-200
-43% -$11K ﹤0.01% 636
2020
Q4
$25K Buy
467
+41
+10% +$2.13K ﹤0.01% 552
2020
Q3
$20K Hold
426
﹤0.01% 548
2020
Q2
$22K Hold
426
﹤0.01% 536
2020
Q1
$20K Hold
426
﹤0.01% 524
2019
Q4
$22K Hold
426
﹤0.01% 581
2019
Q3
$20K Hold
426
﹤0.01% 563
2019
Q2
$20K Buy
426
+226
+113% +$10.4K ﹤0.01% 546
2019
Q1
$10K Hold
200
﹤0.01% 609
2018
Q4
$9K Hold
200
﹤0.01% 643
2018
Q3
$11K Hold
200
﹤0.01% 589
2018
Q2
$10K Hold
200
﹤0.01% 620
2018
Q1
$13K Hold
200
﹤0.01% 608
2017
Q4
$12K Hold
200
﹤0.01% 657
2017
Q3
$13K Buy
+200
New +$14.1K ﹤0.01% 593

Other funds holding CAH

Covington Capital Management's CAH Position: Q3 2022 in Review

Covington Capital Management opened a new position in Cardinal Health (CAH) in Q3 2022: 100 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #864 among its holdings. This is a return to the name: Covington Capital Management previously reported a position in CAH as recently as Q1 2021.

Covington Capital Management first reported a position in CAH in Q3 2017 and has held it in 16 quarters since. The position peaked at $25K in Q4 2020. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

  • Covington Capital Management held 100 shares of Cardinal Health worth $7K as of Q3 2022.
  • Cardinal Health was a new Covington Capital Management position in Q3 2022.
  • Cardinal Health made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #864 holding.
  • Covington Capital Management first reported a position in Cardinal Health in Q3 2017 and has held it in 16 quarters since.
  • Covington Capital Management's Cardinal Health position peaked at $25K in Q4 2020.
  • 849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.